Aubrey Rankin - Director at Revance Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RVNC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Aubrey Rankin since 12/25/2023

Holdings reported by Aubrey Rankin for Revance Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 322K $2.4M $7.47 Mar 15, 2022 Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Common Stock 154K $1.15M $7.47 Mar 15, 2022 The Rankin Irrevocable Trust
Common Stock 94.1K $703K $7.47 Mar 15, 2022 Direct

Transactions reported by Aubrey Rankin for Revance Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.